Osteoporosis Bone Marker Panel

A blood test measuring bone turnover markers used to monitor osteoporosis and the response to treatment — giving an early indication of whether therapy is working, well before a repeat bone-density scan. Available as a walk-in self-pay test at MZ-Biochem.

Osteoporosis is usually diagnosed with a DXA (bone density) scan, but bone-density changes are slow, so a repeat scan is typically only meaningful after about two years. Bone turnover markers, released into the blood as bone tissue is broken down and rebuilt, change far sooner and can indicate whether anti-resorptive treatment is taking effect as early as about three months after starting. This makes the panel a useful complement to DXA for people on osteoporosis therapy who want earlier reassurance, as well as a screening adjunct for those at elevated fracture risk. MZ-Biochem offers the test on a self-pay basis without a referral. Bone marker results must always be interpreted by a physician in the context of the DXA result and overall clinical picture; they support, but do not replace, imaging-based diagnosis.